1. Blood pressure-lowering drugs not considered as antihypertensives

   • Peter M. Nilsson

   Invited Commentary 22 July 2007 Pages: 249 - 250

2. Combinations as a first-step therapy in hypertension

   • Alejandro de la Sierra

   Invited Commentary 22 July 2007 Pages: 251 - 252

3. Literature alert

   OriginalPaper 22 July 2007 Pages: 253 - 256

4. TROPHY for preventing hypertension

   • Helmy M. Siragy

   Clinical Trials Report 22 July 2007 Pages: 259 - 260

5. Secondary analysis of the VALUE trial: Intriguing new questions

   • Michael A. Weber

   Clinical Trials Report 22 July 2007 Pages: 261 - 263

6. Prehypertension: Demographics, pathophysiology, and treatment

   • Joseph L. Izzo Jr

   OriginalPaper 22 July 2007 Pages: 264 - 268

7. The vasodilatory beta-blockers

   • Michala E. Pedersen
   • John R. Cockcroft

   OriginalPaper 22 July 2007 Pages: 269 - 277

8. The effect of angiotensin receptor blockers for preventing atrial fibrillation

   • Kristian Wachtell
   • Richard B. Devereux
   • Paulette A. Lyle

   OriginalPaper 22 July 2007 Pages: 278 - 283

9. Combination therapy with renin-angiotensin system blockers: Will amlodipine replace hydrochlorothiazide?

   • Thor Tejada
   • Alessia Fornoni
   • Barry J. Materson

   OriginalPaper 22 July 2007 Pages: 284 - 290

10. Renin inhibition: A new modality for hypertension management

    • Helmy M. Siragy

    OriginalPaper 22 July 2007 Pages: 291 - 294

11. Spironolactone use in resistant hypertension

    • Dan Carl
    • Domenic A. Sica

    Clinical Trials Report 22 July 2007 Pages: 297 - 298

12. Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials

    • Guido Grassi
    • Francesca Arenare
    • Giuseppe Mancia

    OriginalPaper 22 July 2007 Pages: 299 - 304

13. The metabolic syndrome in hypertension: Diagnostic and therapeutic implications

    • Josep Redon
    • Renata Cífková

    OriginalPaper 22 July 2007 Pages: 305 - 313

14. Dietary salt restriction and blood pressure in clinical trials

    • Daniel T. Lackland
    • Brent M. Egan

    OriginalPaper 22 July 2007 Pages: 314 - 319

15. Chemotherapy agents and hypertension: A focus on angiogenesis blockade

    • Manish Jain
    • Raymond R. Townsend

    OriginalPaper 22 July 2007 Pages: 320 - 328

16. Obstructive sleep apnea, hypertension, and wakefulness-promoting agents

    • Dan Carl
    • Domenic A. Sica

    OriginalPaper 22 July 2007 Pages: 329 - 331

17. Effects of thiazolidinediones on blood pressure

    • Thomas D. Giles
    • Gary E. Sander

    OriginalPaper 22 July 2007 Pages: 332 - 337